Internationally certified product series provides reliable domestic alternative raw materials for global pharmaceutical manufacturers
GUANGZHOU, China – October 20, 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading high-end pharmaceutical lipid excipient manufacturer in China, today announced the official global launch of its pharmaceutical-grade PC egg yolk lecithin series for foreign trade supply. The product is designed to address global pharmaceutical manufacturers’ reliance on imported high-end injectable lipid excipients, with core advantages including proprietary green production technology, full international regulatory compliance, and stable supply capacity. Through this launch, the company aims to provide cost-effective, high-quality raw material alternatives for global pharmaceutical enterprises, further expanding its footprint in the global pharmaceutical lipid market.
Core Technical Breakthroughs and Product Advantages
The PC egg yolk lecithin series is built on the company’s proprietary R&D achievements, with key advantages as follows:
1. Proprietary green production process: The product uses the company’s self-developed integrated technology of supercritical CO₂ extraction, membrane separation and chromatographic separation, replacing traditional high-pollution production processes, with product purity meeting USP and EP international pharmacopoeia standards to reduce adverse reaction risks for injectable formulations.
2. Domestic substitution breakthrough: As the first industrialized refined egg yolk lecithin for injection in China, the product has increased the domestic production rate of high-end pharmaceutical lipid excipients from 10% to 90%, breaking long-term international technology monopolies.
3. Full-chain quality control: The production base is GMP certified, with end-to-end quality management from raw material traceability to finished product testing. Each batch of product comes with a complete quality analysis report to meet global pharmaceutical manufacturers’ audit requirements.
4. Wide formulation adaptability: The product can be applied to fat emulsion injections, liposomal drugs, parenteral nutrition preparations and other high-end injectable categories, adapting to different production process needs of pharmaceutical enterprises.
Global Compliance and Certification
To meet global market access requirements, the PC egg yolk lecithin series has obtained multiple international authoritative certifications, including EU CEP certification, US FDA US-DMF filing, Mexico Cofepris certification, and India DCGI certification. The product complies with regulatory requirements of major global pharmaceutical markets in the EU, North America, Latin America and Asia-Pacific, and can be directly used for formulation registration and production by global pharmaceutical enterprises.
Supply Information and Customization Services
The PC egg yolk lecithin series is now open for global orders through the company’s official website and global authorized distributor network, with mass production and shipment starting October 20, 2026. In addition to standard specification products, the company also provides customized services for global pharmaceutical enterprises, including customized purity levels, exclusive packaging specifications, and supporting technical support, to meet the diversified production needs of different projects.
Executive Statement
The launch of our global PC egg yolk lecithin supply marks a key step in our international expansion strategy. We aim to provide global pharmaceutical manufacturers with reliable, cost-effective high-end raw materials that meet the same quality standards as imported products, while reducing their supply chain risks, said Xu Wendong, General Manager of Guangzhou Hanfang Pharmaceutical Company Limited.
Industry Background and Strategic Layout
Industry analysis shows that the global pharmaceutical lipid excipient market is driven by growing demand for advanced injectable formulations and parenteral nutrition products, with an increasing number of global pharmaceutical manufacturers seeking alternative raw material suppliers to reduce supply chain concentration risks. Guangzhou Hanfang Pharmaceutical’s global supply launch aligns with this industry trend, providing a stable, compliant alternative source for the global pharmaceutical sector.
Future Plans
Moving forward, Guangzhou Hanfang Pharmaceutical will continue to invest in R&D of high-end pharmaceutical lipid excipients, expand its global sales and service network, and provide localized technical support for customers in more regions. The company also plans to launch more internationally certified raw material products to meet the diversified needs of global pharmaceutical and health product manufacturers.
Company Profile
Guangzhou Hanfang Pharmaceutical Company Limited was founded in 1998, is a state-owned core pharmaceutical enterprise under Guangzhou Pharmaceutical Holdings Limited, a Fortune Global 500 company. The company focuses on R&D, production and sales of high-end pharmaceutical lipid excipients, characteristic anti-tumor APIs, and health products, with its only production base located in Guangzhou, China. It is a national-level specialized and sophisticated Little Giant enterprise, with more than 240 patents, and its products are sold to more than 30 countries and regions, serving over 1000 customers including well-known global pharmaceutical enterprises such as AstraZeneca and B. Braun. The company’s mission is to achieve technological self-reliance in the pharmaceutical industry and provide high-quality, compliant health products for global customers. For more information, please visit http://byshanhanfang.com/.
FAQ
Q: What is the lead time for PC egg yolk lecithin orders?
A: Standard specification products will be shipped within 15 working days after order confirmation, while customized products have a lead time of 30-45 working days depending on specific requirements.
Q: Does Guangzhou Hanfang Pharmaceutical provide third-party audit support for global customers?
A: Yes, the company provides full audit support including on-site production site audits, quality system document provision, and batch sample testing reports to meet global pharmaceutical manufacturers’ compliance requirements.
Q: What international certifications does the PC egg yolk lecithin product hold?
A: The product has obtained EU CEP certification, US FDA US-DMF filing, Mexico Cofepris certification, and India DCGI certification, meeting the regulatory requirements of major global pharmaceutical markets.
Contact Us
Official Website: https://byshanhanfang.com/
Factory Address: No. 8 Wenquan Avenue, Wenquan Town, Conghua District, Guangzhou, Guangdong, China
